XDR typhoid in Pakistan: what to give, and what not to trust

Pakistan is where extensively drug-resistant typhoid was first described, and it remains the country where a febrile patient not responding to ceftriaxone should make you think of it. If you trained on "enteric fever, start ceftriaxone, done", the ground has moved — and the national society guidance has moved with it.

This is what the MMIDSP Typhoid Management Guidelines 2022 actually say, including the parts most likely to change what you do on Monday.

Start with the thing most often got wrong

The guideline is unambiguous, and it is worth quoting directly:

Positive serological tests (such as Widal and TyphiDOT) are not recommended for diagnosis of enteric fever and are not included in case definitions of typhoid. Serological tests should never be ordered or relied upon to diagnose or rule out enteric fever.

Not "interpret with caution". Not "use alongside clinical judgement". Never ordered or relied upon. The Widal test remains in daily use across Pakistan, and it is generating both false reassurance and false diagnoses — a positive Widal in an endemic population tells you very little, and a negative one rules out nothing.

The case definition is blood culture. Two sets, ideally before antibiotics are started, and also in patients already on antibiotics who are not responding. Automated cultures can flag positive as early as 4 hours, with identification and susceptibility following within about 48 hours.

That 48-hour window is the whole reason the culture matters: it is what tells you which of four different treatment paths your patient is on.

The four categories

MMIDSP classifies confirmed typhoid by resistance pattern. First-line drugs means chloramphenicol, ampicillin and co-trimoxazole; second-line means the fluoroquinolones.

The distinction that matters clinically is between MDR and XDR. In MDR typhoid, ceftriaxone still works — that was the whole point of moving to cephalosporins in the first place. In XDR typhoid, ceftriaxone fails, because the strain carries an ESBL that hydrolyses it. A patient given ceftriaxone for XDR typhoid is receiving no effective treatment at all while their illness progresses.

That fourth category is an MMIDSP addition, added on reports of strains resistant to third-generation cephalosporins but still sensitive to older agents — which is why an ESBL-positive result is not automatically an XDR result, and why the susceptibility report deserves reading properly rather than pattern-matching.

What to give, by category

Non-resistant typhoid

De-escalate to any first-line option and complete 14 days. Ceftriaxone 1 g q12h or 2 g q24h; cefixime 400 mg q12h; ciprofloxacin 500–750 mg q12h orally; chloramphenicol 500 mg q6h; co-trimoxazole 160/800 mg q12h; or ampicillin/amoxicillin 1000–2000 mg q6h.

MDR typhoid

De-escalate to cephalosporins; IV can be switched to oral cefixime. The guideline is specific that at least 14 days of cephalosporin therapy must be completed, warning that shorter courses may lead to relapse.

XDR typhoid

If the patient is clinically stable, azithromycin dosed by weight:

• Under 60 kg — 1 g oral loading dose, then 500 mg every 24 hours for 7–10 days
• Over 60 kg — 1 g every 24 hours for 7–10 days
• Children — 8–10 mg/kg

If the patient cannot take orally, is haemodynamically unstable, is deteriorating rapidly or develops complications, admit or refer to a tertiary centre and use a carbapenem: imipenem 500 mg q6h, meropenem 1 g q8h, or ertapenem 1 g q24h, each for 10–14 days. Once improving and tolerating oral intake, de-escalate to oral azithromycin to complete a total of 14 days.

ESBL-positive typhoid

If the strain is sensitive to chloramphenicol, co-trimoxazole or a fluoroquinolone, use one of those first-line options in a stable patient — or de-escalate to it after initial carbapenem or azithromycin. Complete 14 days.

The empiric question, answered honestly

Here is where we have to be straight with you. The guideline states two different empiric regimens in two different sections.

Under Management guidelines, it says to commence empirical treatment with either oral cefixime or IV ceftriaxone depending on severity. Under Treatment → Empiric treatment, it says to start oral azithromycin or an IV carbapenem based on clinical status.

In a setting with high XDR prevalence these are not interchangeable — cefixime and ceftriaxone are precisely the agents XDR strains defeat. We are not going to pretend the document says one thing when it says two. Our tool shows both statements with their sections and makes no recommendation, because the right answer depends on the XDR prevalence in your catchment and on how sick the patient in front of you is. Discuss it with your microbiology service, and know which way your local isolates are running.

What the guideline is unambiguous about is escalation: if initial therapy was oral and there is no clinical improvement after 5 days, or any sign of complications appears, switch to an IV carbapenem. And if there is still no improvement after at least 48 hours of IV therapy with cultures remaining negative, refer to a secondary or tertiary centre and re-examine the diagnosis.

Do not rush to change antibiotics

This is the practice point that prevents the most unnecessary escalation:

Fever defervescence is prolonged in typhoid fever and may take 5–7 days to improve. Do not rush to change antibiotics, monitor for improvement in frequency and intensity of fever.

A patient still spiking on day 3 of appropriate therapy is not necessarily failing treatment. The guideline adds a useful clinical marker: appetite and general condition often improve before the fever does. If your patient is eating, sitting up and looking better while still running a temperature, that is the treatment working.

What should prompt concern is different: abdominal distension, tenderness, vomiting, a falling GCS, or bicytopenia on the blood count.

When it is complicated

Suspected or culture-proven enteric fever with jaundice, drowsiness, severe abdominal pain, intestinal haemorrhage, severe sepsis or septic shock is complicated typhoid, and the guideline directs that these patients be managed at tertiary care centres.

Intestinal perforation and gastrointestinal haemorrhage are the classic catastrophes, and they tend to arrive in the third week. Encephalitis and cranial neuritis also feature. None of these are places to be managing a patient in a facility without surgical cover.

Two things to do after the fever settles

First, always de-escalate. Switch IV to oral once the patient is stable and tolerating, and move from broad- to narrow-spectrum once a susceptible strain is isolated. Typhoid is usually treated with a single agent — combination therapy is not the default.

Second, follow up for three months. The guideline asks that patients be monitored for relapse or complications for 3 months after treatment commenced. Relapse after apparently successful treatment is well described, and chronic carriage is how the next outbreak starts.

The prevention side

Pakistan introduced typhoid conjugate vaccine into routine immunisation after the XDR outbreak began in Sindh in 2016 — the first country in the world to do so. TCV now sits at 9 months on the national EPI schedule, alongside MR-1 and IPV-2. If you are seeing XDR typhoid in adults, the children in that same household have a vaccine available to them; our EPI schedule tool will tell you what is due.

Bottom line

Stop ordering Widal. Send two blood cultures before antibiotics. Read the susceptibility report properly — MDR and XDR are not the same, and ESBL-positive is a third thing again. Give azithromycin by weight in stable XDR patients and a carbapenem in unstable ones. Complete 14 days. Do not panic on day 3 when the fever is still there. And follow up for three months.

Our typhoid management wizard walks through this step by step — suspicion, culture, complicated-case triage, empiric therapy, definitive therapy by resistance category with doses, and follow-up — with every step citing its section of the guideline.

ReviseFCPS1 is built by doctors in Pakistan, for doctors in Pakistan. Our clinical tools are free, including the dengue triage and fluid wizard and the paediatric antibiotic dose calculator. If you are preparing for FCPS Part 1, try it free for 7 days — 10,176 doctor-verified MCQs and 8,236 real exam recalls.